Home/ Supplements/ Electrolytes/ KEYZ Pina Colada

KEYZ Pina Colada

product on market Powder Black Magic Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formula contains electrolytes and amino acids, which have strong evidence for supporting hydration and muscle recovery. L-Taurine and the EAA/BCAA matrix are commonly used to maintain cellular function and protein synthesis. Overall, these ingredients are well-supported by research for athletic performance and recovery.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for KEYZ Pina Colada
Open Full PDF View on NIH DSLD →
Details

Label Data

14 Gram(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

110 mg (26% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
Potassium
65 mg (1% DV)
Sodium
220 mg (10% DV)
EAA/BCAA Matrix
8000 mg
750 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Coconut Water powder
500 mg
Spectra Total ORAC Blend
100 mg
AstraGin
25 mg

Other Ingredients

Natural & Artificial flavors Citric Acid Malic Acid Sucralose Acesulfame-K Silicon Dioxide Colour
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: As a dietary supplement mix 1 level scoop (1 serving) of KEYZ with 8-16 fluid oz. of ice cold water. KEYZ can be consumed before training, during training, post training and between meals to support recovery and fuel physical performance. On non-workout days consume 1 scoop in the morning, noon or night.

Formulation Notes

Powered by: Spectra anti-oxidants

Muscle recovery gains

Designer amino acid matrix Pina Colada Natural & artificially flavored

Additional Information

From the other side Less luck More skill

Metadata

Product Details

DSLD Entry Date2021-03-25
Product TypeOther Combinations
FormPowder
DSLD ID242785
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.